A Novel Case Series of Munchausen Syndrome by Proxy Victim
Abstract
Introduction: Munchausen Syndrome by Proxy or (Caregiver-fabricated illness in a child) is a form of child abuse which entails a child’s illness induced by a caretaker; leading to a series of medical procedures and treatments that are unnecessary and potentially harmful as it may lead to significant morbidity and mortality. Result and Discussion: A 35 year old lady, was married twice. From the 1st marriage she had 2 children (18 year-daughter and 17-year-old son) and from the 2nd marriage she had a (3-year-old daughter). She was known to have social and marital problems and diagnosed as a case of depression and was on multiple antidepressants and attempted suicide several times. She is using her 6-year-old daughter and her 3-year-old grandson for visiting doctors 4-5 times a week. She had a relationship with a neighbor, a young man (SA) who was a driver and transported the mother and her daughter to hospital or the doctor’s clinic. The reasons for doctor visits were different including urinary tract infection, otitis media, gastroenteritis, respiratory infections, different kinds of trauma etc. Conclusion: Munchausen syndrome by proxy is a complex type of abuse, usually misdiagnosed and under-diagnosed, and its sequelae have a significant impact. In Iraq, there are some reported cases of Munchausen syndrome by proxy but it is definitely underestimated. Its diagnosis is associated with social and legal problems concerning perpetrator parent, especially in the absence of a…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.